Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 04/16/2014

Company Name Symbol %Change
BITAUTO HOLD BITA
14.82%
ANI PHARMACE ANIP
14.66%
INTERACTIVE IBKR
11.69%
IMMUNOGEN IN IMGN
11.02%
E HOUSECHINA EJ
9.25%
Questcor Pharmaceuticals has Relatively Underperformed its Peers in the Pharmaceuticals Industry (QCOR, TEVA, VRX, SLXP, FRX)

Print Share

Dec 28, 2012 (Fast Lane via COMTEX) -- Below are five companies in the Pharmaceuticals industry that underperformed yesterday on a relative basis. This analysis was compiled based on yesterday's trading activity as we search for stocks that have could possible underperform its peers going forward.

Questcor Pharmaceuticals (NASDAQ:QCOR) ranks first with a loss of 7.09%; Teva Pharmaceutical Industries (NASDAQ:TEVA) ranks second with a loss of 1.26%; and Valeant Pharmaceuticals International (NYSE:VRX) ranks third with a loss of 1.06%.

Salix Pharmaceuticals (NASDAQ:SLXP) follows with a loss of 1.05% and Forest Laboratories (NYSE:FRX) rounds out the bottom five with a loss of 0.91%.Questcor Pharmaceuticals, Inc. develops and commercializes novel central nervous system-focused therapeutics that address significant unmet medical needs. The Company's primary product is a natural source adrenocorticotropic hormone indicated for the treatment of acute exacerbations of multiple sclerosis, as well as a number of other conditions.

---------------------------------------------------------------------------------------------

Financial News Network Online (FNNO) is a leading provider of digital financial news content for distribution on the web. You can count on FNNO to bring you the latest market news, earnings reports, analyst comments, economic data reports and more. Visit http://www.fnno.com today.

Copyright, Comtex News Network, Inc. 2012

Free Stock Analysis From Zacks

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.